Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

NCT01377285 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Chronic Renal Failure

Interventions

DRUG: ARB
DRUG: Pentoxifylline
DRUG: Placebo (for Pentoxifylline)

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]